In a remarkable feat of medical precision, Kauvery Hospital Alwarpet has saved the life of a 62-year-old man through an ...

We are delighted that we have been awarded this designation,’' said Dr. Philip Otterbeck, RUMC’s chief medical officer.

Peripheral artery disease (PAD) is a common cardiovascular disease associated with increased risk of amputation, myocardial infarction, stroke, and death, as well as impaired quality of life (QOL), ...

The National Institute for Health and Care Excellence (NICE) issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Melphalan chemosaturation with percutaneous hepatic ...

8. Mookiah M, Hogg S, MacGillivray T, Prathiba V, Pradeepa R, Mohan V, et al. review of machine learning methods for retinal blood vessel segmentation and artery/vein classification. Med Image Anal.

Coronary endothelial dysfunction is characterized by an attenuated increase or decrease in coronary blood flow and coronary artery diameter in response to low dose acetylcholine. 68 Impaired ...

Can Regal Envoy continue his rich vein of form by winning another series qualifier? William Knight: hopeful of another big show from Regal Envoy Credit: Ed Whitaker There are ten qualifiers, run over ...

Code Vein got several DLC packs, concluding with Lord of Thunder in March of 2020, and the series has been quiet ever since. If you need a catch up, check out everything announced at Summer Game Fest ...

Code Vein came out back in 2019 and immediately stood apart from other soulslike games for its anime-inspired visual style and more straightforward storytelling. Though it has the demanding combat ...

Bandai Namco has finally answered the prayers of Code Vein fans. Yes, Code Vein 2 is real, and it’s coming in 2026. Revealed during Summer Game Fest 2025, the announcement trailer reignites the ...

Code Vein 2 has been announced. Announced during Summer Game Fest, the game is planned for release on PS5, Xbox Series X/S, and PC in 2026. You can watch the first trailer for Code Vein 2 below. In ...